Address |
4/F, Korea Bio Park Bldg. B Seongnam-si GY 13488 Korea, Republic Of |
Employees | - |
Website | http://www.genexine.com |
Updated | 09/14/2018 |
Genexine, Inc. engages in research and development of therapeutic vaccines hybrid Fc fusion proteins (hyFc) and DNA (deoxyribonucleic acid) therapeutic vaccines. It operates through the following business divisions: Novel drug development and Cell culture media manufacturing. The company was founded by Young Chul Sung on June 8, 1999 and is headquartered in Seongnam, South Korea. |